openPR Logo
Press release

Familial Adenomatous Polyposis Treatment Market Will Generate Record Revenue by 2028

12-24-2022 06:46 AM CET | Health & Medicine

Press release from: Orion Market Research

Familial Adenomatous Polyposis Treatment Market Will Generate

Familial adenomatous polyposis treatment market is anticipated to grow at a significant CAGR during the forecast period. Familial adenomatous polyposis (FAP) is an inherited disorder. It is characterized by the large intestine (colon) . Additionally, the classic type of familial adenomatous polyposis in people begins to occur as early as in their teenage years causing them to develop multiple noncancerous in the colon. The major factor accelerating the growth of the market is the increasing prevalence of familial adenomatous polyposis across the globe. 

According to the National Organization for Rare Disorders (NORD), FAP affects males and females equally and occurs in approximately one in 5,000 to 10,000 individuals in the US. Additionally, it accounts for about 0.5% of all cases of colorectal cancer. Furthermore, it is estimated that it affects almost 50,000 American families. Moreover, as per the American Society of Clinical Oncology (ASCO), it is estimated that most people with FAP will have multiple colon polyps by age 35 and approximately 30% of people with FAP do not have any family history of the condition. Further, it is estimated that people affected with FAP have a 100% risk of colorectal cancer if polyps are not removed. Hence, the rising prevalence of the disease is driving the demand for familial adenomatous polyposis treatment.

To Request a Sample of our Report on Familial Adenomatous Polyposis Treatment Market:   https://www.omrglobal.com/request-sample/familial-adenomatous-polyposis-treatment-market

Some major players operating in the market include Cancer Prevention Pharmaceuticals Inc, Marina Biotech, Inc, and Thetis Pharmaceuticals LLC, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2020, Cancer Prevention Pharmaceuticals, Inc. announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA). It was aimed to receive accelerated approval for CPP-1X/sul for the treatment of adults with familial adenomatous polyposis (FAP).

Market Coverage

The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028

Segment Covered- 

By Type
By Application

Regions Covered-

North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape- Cancer Prevention Pharmaceuticals Inc, Marina Biotech Inc, and Thetis Pharmaceuticals LLC, among others. 

Familial Adenomatous Polyposis Treatment Market Report by Segment

By Type

Icosapent
Eflornithine Hydrochloride
Aspirin
CEQ-508 
Others

By Application

Hospital 
Clinics
Others

A full Report of Familial Adenomatous Polyposis Treatment Market is Available @ https://www.omrglobal.com/industry-reports/familial-adenomatous-polyposis-treatment-market

Familial Adenomatous Polyposis Treatment Market Report by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

https://sportmsr.com/%d8%b3%d9%88%d9%82-%d8%b9%d9%84%d8%a7%d8%ac-%d8%a3%d9%85%d8%b1%d8%a7%d8%b6-%d8%a7%d9%84%d9%83%d9%84%d9%89-%d9%81%d9%8a-%d8%a7%d9%84%d9%85%d8%b1%d8%ad%d9%84%d8%a9-%d8%a7%d9%84%d9%86%d9%87%d8%a7%d8%a6/
https://revistaeconomiasocial.com/2022/12/23/el-mercado-del-sistema-de-recoleccion-de-energia-sera-testigo-de-la-aceleracion-del-crecimiento-para-2028/
https://citytoday-hildesheim.de/index.php/2022/12/23/energy-harvesting-system-markt-weltweite-branchenanalyse-zukunftige-nachfrage-und-prognose-bis-2028/
https://www.asiatimeskorea.com/news/2028%eb%85%84%ea%b9%8c%ec%a7%80-%ec%97%84%ec%b2%ad%eb%82%9c-%ec%84%b1%ec%9e%a5%ec%9d%84-%eb%b3%b4%ec%9d%bc-%ed%94%84%eb%9e%91%ec%8a%a4-%ed%99%94%ec%9e%a5%ed%92%88-%ed%8f%ac%ec%9e%a5-%ec%8b%9c%ec%9e%a5/199109/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Familial Adenomatous Polyposis Treatment Market Will Generate Record Revenue by 2028 here

News-ID: 2861733 • Views:

More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sustainability Preferences
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become
Railway Management System Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033. Railway Management System Market Overview The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033. Monocalcium Phosphate Market Overview Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033. Automotive Lubricants Market Overview The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by

All 5 Releases


More Releases for Familial

Homozygous Familial Hypercholesterolemia Market Outlook 2024-2034
Introduction Homozygous familial hypercholesterolemia (HoFH) is a rare, life-threatening genetic disorder characterized by extremely high cholesterol levels from birth. Patients with HoFH are at a very high risk of premature atherosclerotic cardiovascular disease (ASCVD), often developing complications as early as childhood. While the condition is rare-affecting approximately 1 in 160,000 to 300,000 individuals globally-it has become a major focus for pharmaceutical innovation due to the severity of the disease and the
Familial Adenomatous Polyposis (FAP) Therapeutics- Pipeline Analysis 2018
Familial adenomatous polyposis (FAP) is a genetic disorder, characterized by the development of adenomatous colon polyps in the intestinal tract, resulting in colon cancer. The disease is diagnosed when more than 100 adenomatous colon polyps are developed in a person. Download the sample report at: https://www.pharmaproff.com/request-sample/1025 A person with FAP is at a high risk of developing cancer of small intestines or stomach. This disease is categorized into three types including attenuated
Heterozygous Familial Hypercholesterolemia (heFH) Therapeutics - Pipeline Analys …
Heterozygous familial hypercholesterolemia (HeFH) is an inherited genetic disorder that affects the body’s ability to control cholesterol. It is characterized by very high LDL (low density lipoprotein) cholesterol (above 190 for adults or above 160 for children) and family history of high cholesterol, heart disease or stroke. Download the sample report @ https://www.pharmaproff.com/request-sample/1135 A very high level of LDL from birth leads to a twenty-fold increase in the risk of premature
Familial Amyloid Cardiomyopathy Treatment Market Opportunity Analysis, 2018–20 …
Aggregation and deposition of mutant and wild-type transthyretin protein (TTR) in heart results in familial amyloid cardiomyopathy, which typically occur after age of 60. Familial amyloid cardiomyopathy is also known as hereditary cardiac transthyretin amyloidosis or hereditary amyloid cardiomyopathy. The protein transthyretin amyloid fibrils infiltrate the myocardium that leads to diastolic dysfunction from restrictive cardiomyopathy, which eventually result to heart failure. There are several mutation in TTR which are associated
Familial Adenomatous Polyposis Pipeline Therapeutics Development Market Review 2 …
RnRMarketResearch.com adds “Familial Adenomatous Polyposis - Pipeline Review, H1 2017” to its store providing an overview of the Familial Adenomatous Polyposis therapeutic pipeline with comprehensive information on the therapeutic development for Familial Adenomatous Polyposis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews
Familial Adenomatous Polyposis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Familial Adenomatous Polyposis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Familial Adenomatous Polyposis - Pipeline Review, H1 2017, provides an overview of the Familial Adenomatous Polyposis (Genetic Disorders) pipeline landscape. Familial adenomatous polyposis (FAP) is also known as familial polyposis coli, adenomatous polyposis coli, or